Skip to main content
Erschienen in: Journal of Neurology 1/2013

01.01.2013 | Original Communication

Accumulation of non-compressive fascicular lesions underlies NF2 polyneuropathy

verfasst von: P. Bäumer, V. F. Mautner, T. Bäumer, M. U. Schuhmann, M. Tatagiba, S. Heiland, T. Kaestel, M. Bendszus, M. Pham

Erschienen in: Journal of Neurology | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

A distinct polyneuropathy (PNP) syndrome affects up to 66 % of patients with neurofibromatosis II (NF2). Whether this is primarily a diffuse PNP or due to single, surgically amenable mass lesions has not yet been conclusively demonstrated. We aimed to solve this question by investigating the pathomorphological MR imaging correlate of this rare disorder. Eight patients with NF2-PNP were characterized by clinical examination, electrophysiological studies, and genetic analysis. All patients additionally underwent extended peripheral nerve imaging by a novel protocol of large-coverage high-resolution MRI. Quantitative analyses were performed by separately evaluating cross-sectional images, and by categorizing lesions into non-compressive fascicular microlesions (<2 mm), intermediate lesions (2–5 mm), and compressive macrolesions (>5 mm). The predominant imaging findings were non-compressive fascicular microlesions and intermediate lesions. Proximal-to-distal cumulative lesion burden of these lesions correlated strongly with the severity of clinical symptoms of NF2-PNP. In contrast, compressive macrolesions were not found at all in several symptomatic extremities. We conclude that proximal-to-distal accumulation of non-compressive fascicular lesions instead of compressive mass lesions predominantly underlies the clinical manifestation and severity of NF2-associated PNP. Diagnostic management may now be assisted by large-coverage high-resolution imaging of plexus and peripheral nerves. Additionally, the results underscore the feasibility of this new method, which may open up new diagnostic and investigative possibilities for other disseminated disorders of the peripheral nervous system.
Literatur
2.
Zurück zum Zitat Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A, Viskochil D (1997) The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278(1):51–57PubMedCrossRef Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A, Viskochil D (1997) The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278(1):51–57PubMedCrossRef
3.
Zurück zum Zitat Evans DG, Baser ME, O’Reilly B, Rowe J, Gleeson M, Saeed S, King A, Huson SM, Kerr R, Thomas N, Irving R, MacFarlane R, Ferner R, McLeod R, Moffat D, Ramsden R (2005) Management of the patient and family with neurofibromatosis 2: a consensus conference statement. Br J Neurosurg 19(1):5–12. doi:10.1080/02688690500081206 PubMedCrossRef Evans DG, Baser ME, O’Reilly B, Rowe J, Gleeson M, Saeed S, King A, Huson SM, Kerr R, Thomas N, Irving R, MacFarlane R, Ferner R, McLeod R, Moffat D, Ramsden R (2005) Management of the patient and family with neurofibromatosis 2: a consensus conference statement. Br J Neurosurg 19(1):5–12. doi:10.​1080/​0268869050008120​6 PubMedCrossRef
6.
Zurück zum Zitat Onishi A, Nada O (1972) Ultrastructure of the onion bulb-like lamellated structure observed in the sural nerve in a case of von Recklinghausen’s disease. Acta Neuropathol 20(3):258–263PubMedCrossRef Onishi A, Nada O (1972) Ultrastructure of the onion bulb-like lamellated structure observed in the sural nerve in a case of von Recklinghausen’s disease. Acta Neuropathol 20(3):258–263PubMedCrossRef
7.
Zurück zum Zitat Bosch EP, Murphy MJ, Cancilla PA (1981) Peripheral neurofibromatosis and peroneal muscular atrophy. Neurology 31(11):1408–1414PubMedCrossRef Bosch EP, Murphy MJ, Cancilla PA (1981) Peripheral neurofibromatosis and peroneal muscular atrophy. Neurology 31(11):1408–1414PubMedCrossRef
9.
Zurück zum Zitat Evans DG, Huson SM, Donnai D, Neary W, Blair V, Newton V, Harris R (1992) A clinical study of type 2 neurofibromatosis. Q J Med 84(304):603–618PubMed Evans DG, Huson SM, Donnai D, Neary W, Blair V, Newton V, Harris R (1992) A clinical study of type 2 neurofibromatosis. Q J Med 84(304):603–618PubMed
10.
Zurück zum Zitat Kilpatrick TJ, Hjorth RJ, Gonzales MF (1992) A case of neurofibromatosis 2 presenting with a mononeuritis multiplex. J Neurol Neurosurg Psychiatry 55(5):391–393PubMedCrossRef Kilpatrick TJ, Hjorth RJ, Gonzales MF (1992) A case of neurofibromatosis 2 presenting with a mononeuritis multiplex. J Neurol Neurosurg Psychiatry 55(5):391–393PubMedCrossRef
11.
Zurück zum Zitat Overweg-Plandsoen WC, Brouwer-Mladin R, Merel P, de Vries L, Bijlsma EK (1996) Neurofibromatosis type 2 in an adolescent boy with polyneuropathy and a mutation in the NF2 gene. J Neurol 243(10):724–726PubMedCrossRef Overweg-Plandsoen WC, Brouwer-Mladin R, Merel P, de Vries L, Bijlsma EK (1996) Neurofibromatosis type 2 in an adolescent boy with polyneuropathy and a mutation in the NF2 gene. J Neurol 243(10):724–726PubMedCrossRef
13.
Zurück zum Zitat Hagel C, Lindenau M, Lamszus K, Kluwe L, Stavrou D, Mautner VF (2002) Polyneuropathy in neurofibromatosis 2: clinical findings, molecular genetics and neuropathological alterations in sural nerve biopsy specimens. Acta Neuropathol 104(2):179–187. doi:10.1007/s00401-002-0535-7 PubMedCrossRef Hagel C, Lindenau M, Lamszus K, Kluwe L, Stavrou D, Mautner VF (2002) Polyneuropathy in neurofibromatosis 2: clinical findings, molecular genetics and neuropathological alterations in sural nerve biopsy specimens. Acta Neuropathol 104(2):179–187. doi:10.​1007/​s00401-002-0535-7 PubMedCrossRef
14.
Zurück zum Zitat Sperfeld AD, Hein C, Schroder JM, Ludolph AC, Hanemann CO (2002) Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2. Brain 125(Pt 5):996–1004PubMedCrossRef Sperfeld AD, Hein C, Schroder JM, Ludolph AC, Hanemann CO (2002) Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2. Brain 125(Pt 5):996–1004PubMedCrossRef
15.
Zurück zum Zitat Kuo HC, Chen SR, Jung SM, Wu Chou YH, Huang CC, Chuang WL, Wei KC, Ro LS (2010) Neurofibromatosis 2 with peripheral neuropathies: electrophysiological, pathological and genetic studies of a Taiwanese family. Neuropathology. doi:10.1111/j.1440-1789.2009.01099.x Kuo HC, Chen SR, Jung SM, Wu Chou YH, Huang CC, Chuang WL, Wei KC, Ro LS (2010) Neurofibromatosis 2 with peripheral neuropathies: electrophysiological, pathological and genetic studies of a Taiwanese family. Neuropathology. doi:10.​1111/​j.​1440-1789.​2009.​01099.​x
16.
Zurück zum Zitat Trivedi R, Byrne J, Huson SM, Donaghy M (2000) Focal amyotrophy in neurofibromatosis 2. J Neurol Neurosurg Psychiatry 69(2):257–261PubMedCrossRef Trivedi R, Byrne J, Huson SM, Donaghy M (2000) Focal amyotrophy in neurofibromatosis 2. J Neurol Neurosurg Psychiatry 69(2):257–261PubMedCrossRef
17.
Zurück zum Zitat Gijtenbeek JM, Gabreels-Festen AA, Lammens M, Zwarts MJ, van Engelen BG (2001) Mononeuropathy multiplex as the initial manifestation of neurofibromatosis type 2. Neurology 56(12):1766–1768PubMedCrossRef Gijtenbeek JM, Gabreels-Festen AA, Lammens M, Zwarts MJ, van Engelen BG (2001) Mononeuropathy multiplex as the initial manifestation of neurofibromatosis type 2. Neurology 56(12):1766–1768PubMedCrossRef
18.
Zurück zum Zitat Grazzi L, Chiapparini L, Parati EA, Giombini S, D’Amico D, Leone M, Bussone G (1998) Type II neurofibromatosis presenting as quadriceps atrophy. Ital J Neurol Sci 19(2):94–96PubMedCrossRef Grazzi L, Chiapparini L, Parati EA, Giombini S, D’Amico D, Leone M, Bussone G (1998) Type II neurofibromatosis presenting as quadriceps atrophy. Ital J Neurol Sci 19(2):94–96PubMedCrossRef
19.
Zurück zum Zitat Cai W, Kassarjian A, Bredella MA, Harris GJ, Yoshida H, Mautner VF, Wenzel R, Plotkin SR (2009) Tumor burden in patients with neurofibromatosis types 1 and 2 and schwannomatosis: determination on whole-body MR images. Radiology 250(3):665–673. doi:10.1148/radiol.2503080700 PubMedCrossRef Cai W, Kassarjian A, Bredella MA, Harris GJ, Yoshida H, Mautner VF, Wenzel R, Plotkin SR (2009) Tumor burden in patients with neurofibromatosis types 1 and 2 and schwannomatosis: determination on whole-body MR images. Radiology 250(3):665–673. doi:10.​1148/​radiol.​2503080700 PubMedCrossRef
24.
Zurück zum Zitat Baumer P, Dombert T, Staub F, Kaestel T, Bartsch AJ, Heiland S, Bendszus M, Pham M (2011) Ulnar neuropathy at the elbow: MR neurography–nerve T2 signal increase and caliber. Radiology 260(1):199–206. doi:10.1148/radiol.11102357 PubMedCrossRef Baumer P, Dombert T, Staub F, Kaestel T, Bartsch AJ, Heiland S, Bendszus M, Pham M (2011) Ulnar neuropathy at the elbow: MR neurography–nerve T2 signal increase and caliber. Radiology 260(1):199–206. doi:10.​1148/​radiol.​11102357 PubMedCrossRef
25.
Zurück zum Zitat Pham M, Oikonomou D, Baumer P, Bierhaus A, Heiland S, Humpert PM, Nawroth PP, Bendszus M (2011) Proximal neuropathic lesions in distal symmetric diabetic polyneuropathy: findings of high-resolution magnetic resonance neurography. Diabetes Care 34(3):721–723. doi:10.2337/dc10-1491 PubMedCrossRef Pham M, Oikonomou D, Baumer P, Bierhaus A, Heiland S, Humpert PM, Nawroth PP, Bendszus M (2011) Proximal neuropathic lesions in distal symmetric diabetic polyneuropathy: findings of high-resolution magnetic resonance neurography. Diabetes Care 34(3):721–723. doi:10.​2337/​dc10-1491 PubMedCrossRef
27.
Zurück zum Zitat Parry DM, Eldridge R, Kaiser-Kupfer MI, Bouzas EA, Pikus A, Patronas N (1994) Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet 52(4):450–461. doi:10.1002/ajmg.1320520411 PubMedCrossRef Parry DM, Eldridge R, Kaiser-Kupfer MI, Bouzas EA, Pikus A, Patronas N (1994) Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet 52(4):450–461. doi:10.​1002/​ajmg.​1320520411 PubMedCrossRef
28.
Zurück zum Zitat Stemmer-Rachamimov AO, Ino Y, Lim ZY, Jacoby LB, MacCollin M, Gusella JF, Ramesh V, Louis DN (1998) Loss of the NF2 gene and merlin occur by the tumorlet stage of schwannoma development in neurofibromatosis 2. J Neuropathol Exp Neurol 57(12):1164–1167PubMedCrossRef Stemmer-Rachamimov AO, Ino Y, Lim ZY, Jacoby LB, MacCollin M, Gusella JF, Ramesh V, Louis DN (1998) Loss of the NF2 gene and merlin occur by the tumorlet stage of schwannoma development in neurofibromatosis 2. J Neuropathol Exp Neurol 57(12):1164–1167PubMedCrossRef
29.
Zurück zum Zitat Does MD, Snyder RE (1996) Multiexponential T2 relaxation in degenerating peripheral nerve. Magn Reson Med 35(2):207–213PubMedCrossRef Does MD, Snyder RE (1996) Multiexponential T2 relaxation in degenerating peripheral nerve. Magn Reson Med 35(2):207–213PubMedCrossRef
31.
Zurück zum Zitat Evans DG, Huson SM, Donnai D, Neary W, Blair V, Newton V, Strachan T, Harris R (1992) A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling. J Med Genet 29(12):847–852PubMedCrossRef Evans DG, Huson SM, Donnai D, Neary W, Blair V, Newton V, Strachan T, Harris R (1992) A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling. J Med Genet 29(12):847–852PubMedCrossRef
Metadaten
Titel
Accumulation of non-compressive fascicular lesions underlies NF2 polyneuropathy
verfasst von
P. Bäumer
V. F. Mautner
T. Bäumer
M. U. Schuhmann
M. Tatagiba
S. Heiland
T. Kaestel
M. Bendszus
M. Pham
Publikationsdatum
01.01.2013
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 1/2013
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-012-6581-8

Weitere Artikel der Ausgabe 1/2013

Journal of Neurology 1/2013 Zur Ausgabe

Techniques in Clinical Science

Diffusion imaging in neurological disease

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.